Tennis Elbow Release
Lateral epicondyle release (open + arthroscopic) for tennis elbow — FRCS/FRACS exam preparation
Reviewed by OrthoVellum Editorial Team
Editorial maintenance, source checking, and correction workflow • Published by OrthoVellum Medical Education Team
Lateral Epicondyle | ECRB Origin | Open + Arthroscopic | Elbow
Surgical Imaging



4 Critical Danger Zones — Tennis Elbow Release
Danger Zone 1: Posterior Interosseous Nerve (PIN)
Location: 1-2 cm distal to the radial head, wrapping around the radial neck within the supinator muscle through the arcade of Frohse.
Risk: Excessive distal dissection during open release or aggressive arthroscopic shaving that extends beyond the radial neck. Injury causes finger and wrist extensor paralysis (motor only — no sensory loss).
Protection: Limit distal dissection to the immediate origin of ECRB at the lateral epicondyle. Never dissect more than 1 cm distal to the radiocapitellar joint line. Keep dissection strictly at the anterior facet of the lateral epicondyle.
Danger Zone 2: Lateral Collateral Ligament Complex (LCL)
Location: The lateral ulnar collateral ligament (LUCL) and radial collateral ligament (RCL) originate from the lateral epicondyle, immediately deep to the ECRB tendon origin.
Risk: Over-aggressive release extending posterior to the midline of the lateral epicondyle will detach the LCL complex, causing posterolateral rotatory instability (PLRI).
Protection: Restrict release to the anterior facet only. Never release posterior to the equator of the lateral epicondyle. Identify and preserve the LCL complex before dividing any tissue.
Danger Zone 3: Radiocapitellar Joint
Location: Immediately deep to the ECRB origin; the joint capsule lies under the extensor origin.
Risk: Unintentional entry into the joint during open release, or iatrogenic cartilage damage with the arthroscopic shaver.
Protection: For open release, excise only the abnormal grey-grey tendinous tissue and perform decortication without entering the joint unless OCD of the capitellum is suspected. For arthroscopic release, visualise the capsule before activating the shaver.
Danger Zone 4: ECRB versus ECRL
Location: ECRL originates from the lateral supracondylar ridge (proximal and superficial to ECRB). ECRB originates from the anterior facet of the lateral epicondyle (deeper and more distal).
Risk: Releasing the ECRL instead of (or in addition to) ECRB removes a functioning extensor and causes radial wrist extensor weakness without benefit.
Protection: Identify the correct plane by following the supracondylar ridge proximally. ECRB lies beneath the ECRL at the epicondyle. Release only the pathological grey, glistening, avascular tissue at the ECRB origin.
ECRBECRB — The Pathological Tendon
Hook:ECRB is the tendon, angiofibroblastic hyperplasia is the pathology — not tendinitis, never inflamed!
COPECOPE — Conservative Treatment Ladder
Hook:COPE with the conservative ladder for 6-12 months before considering surgery!
Diagnosis
Clinical Features:
- Lateral elbow pain, insidious onset, worse with gripping and lifting
- Tenderness maximal 1 cm distal and anterior to the lateral epicondyle (ECRB origin)
- Cozen test (resisted wrist extension with elbow extended, forearm pronated) — reproduces pain
- Mills test (passive wrist flexion with elbow extended, forearm pronated) — reproduces pain
- Maudsley test (resisted middle finger extension) — positive if ECRB involved
Investigations:
- X-ray: Usually normal; occasionally calcification at lateral epicondyle
- MRI: Signal change at ECRB origin (anterior facet, lateral epicondyle); partial or full-thickness tendon tears; not required for diagnosis but useful pre-operatively for operative planning and to exclude other pathology
- Ultrasound: Hypoechoic area, tendon thickening, neovascularisation at origin
Conservative Treatment Ladder
| Step | Treatment | Evidence |
|---|---|---|
| 1 | Activity modification, NSAIDs, physiotherapy (stretching, eccentric exercises) | First-line; 80-85% resolve without surgery |
| 2 | Counterforce forearm orthosis (brace) | Reduces ECRB load; symptom relief in 60-70% |
| 3 | Corticosteroid injection | Large short-term (4-week) pain reduction but inferior at 26 and 52 weeks vs no/other injection — short-term gain, long-term harm (Coombes et al, Lancet 2010 systematic review) |
| 4 | PRP injection (leukocyte-rich) | No difference vs needling control at 12 weeks, but significantly better at 24 weeks (84% vs 68% success) in the 230-patient RCT (Mishra et al, AJSM 2014) |
| 5 | Extracorporeal shockwave therapy (ESWT) | Reserved for chronic refractory cases; evidence inconsistent across trials |
Nirschl Pathological Staging of Tendinosis
(Conceptual staging of progressive angiofibroblastic tendinosis attributed to Nirschl; the original 1979 Nirschl and Pettrone paper described the angiofibroblastic ECRB lesion itself.)
| Stage | Description |
|---|---|
| 1 | Inflammatory/irritative changes — reversible with conservative management |
| 2 | Angiofibroblastic hyperplasia — pathological tendon, partial (less than 50%) involvement |
| 3 | Angiofibroblastic hyperplasia with structural failure — complete ECRB involvement, grey avascular tendinosis tissue |
| 4 | Stage 2 or 3 plus fibrosis, calcification, or frank tendon rupture — advanced end-stage disease |
Surgical Indications
- Failed conservative treatment for 6-12 months (minimum)
- Failure of at least 2 non-operative modalities
- Persistent functional impairment (inability to work or perform activities of daily living)
- Confirmed diagnosis (clinical +/- MRI/ultrasound)
- Nirschl tendinosis stage 2-3 (established angiofibroblastic change)
Relative contraindications: Active infection, anticoagulation, systemic inflammatory arthropathy (treat underlying disease first), bilateral medial and lateral epicondylitis (may indicate systemic cause)
Evidence: Open versus Percutaneous versus Arthroscopic
| Study | Design | Finding |
|---|---|---|
| Nirschl & Pettrone, JBJS Am 1979 | Case series, 88 elbows | Defined angiofibroblastic hyperplasia; 97.7% overall improvement, 85.2% full return to activity after open ECRB excision/repair |
| Dunkow PD et al, JBJS Br 2004 | RCT, 45 patients (47 elbows) | OPEN vs PERCUTANEOUS tenotomy — percutaneous group returned to work ~3 weeks sooner and improved DASH significantly more |
| Buchbinder R et al, Cochrane 2002 | Systematic review | At time of review, NO controlled trials of surgery existed — cannot conclude surgery is effective vs control |
| Baker CL et al, JSES 2000 | Cohort, 42 arthroscopic releases | Arthroscopic capsular classification (I-III); 37/39 "better/much better" at 2.8 yr, return to work ~2.2 weeks |
| Kholinne E et al, OJSM 2024 | Meta-analysis, 43 studies (1941 elbows) | Success: arthroscopic 91.9%, percutaneous 91.0%, open 82.7%; arthroscopic had best functional gains but evidence is mostly low-level |
Key Evidence
Tennis elbow. The surgical treatment of lateral epicondylitis
A comparison of open and percutaneous techniques in the surgical treatment of tennis elbow
Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials
Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients
Comparison of clinical outcomes after different surgical approaches for lateral epicondylitis: a systematic review and meta-analysis
Clinical Decision Scenarios
Use these scenarios to practise clinical reasoning and management decisions
"A 45-year-old recreational tennis player presents with a 4-month history of lateral elbow pain. She is tender 1 cm distal to the lateral epicondyle, pain is reproduced with resisted wrist extension and passive wrist flexion with the elbow straight. How do you diagnose and manage her?"
"The patient has now failed 12 months of conservative management. You plan an open ECRB release. Walk me through the operative technique, the structures at risk, and the key intra-operative decisions."
"Four months after open tennis elbow release, your patient returns with persistent weakness of finger and wrist extension. How do you assess, investigate, and manage this?"
TENNIS ELBOW RELEASE — EXAM CHEAT SHEET
Clinical summary
References
-
Nirschl RP, Pettrone FA. Tennis elbow. The surgical treatment of lateral epicondylitis. J Bone Joint Surg Am. 1979;61(6A):832-839. PMID: 479229.
-
Dunkow PD, Jatti M, Muddu BN. A comparison of open and percutaneous techniques in the surgical treatment of tennis elbow. J Bone Joint Surg Br. 2004;86(5):701-704. PMID: 15274267.
-
Buchbinder R, Green S, Bell S, Barnsley L, Smidt N, Assendelft WJ. Surgery for lateral elbow pain. Cochrane Database Syst Rev. 2002;(1):CD003525. PMID: 11869670.
-
Coonrad RW, Hooper WR. Tennis elbow: its course, natural history, conservative and surgical management. J Bone Joint Surg Am. 1973;55(6):1177-1182. PMID: 4758032.
-
Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751-1767. PMID: 20970844.
-
Kholinne E, Singjie LC, Anastasia M, Liu F, Anestessia IJ, Kwak JM, Jeon IH. Comparison of clinical outcomes after different surgical approaches for lateral epicondylitis: a systematic review and meta-analysis. Orthop J Sports Med. 2024;12(5):23259671241230291. PMID: 38708009.
-
Baker CL, Murphy KP, Gottlob CA, Curd DT. Arthroscopic classification and treatment of lateral epicondylitis: two-year clinical results. J Shoulder Elbow Surg. 2000;9(6):475-482. PMID: 11155299.
-
Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463-471. PMID: 23825183.
-
Szabo SJ, Savoie FH, Field LD, Ramsey JR, Hosemann CD. Tendinosis of the extensor carpi radialis brevis: an evaluation of three methods of operative treatment. J Shoulder Elbow Surg. 2006;15(6):721-727. PMID: 16963287.